“How can we improve our referrals to our ophthalmologist colleagues?”
is the Qn asked of me to discuss at EM Reg teaching this week. Any advice?
@VGolash@eyesurgery4u@JollyEyeSurgeon @LondonEyeDoc @EyeAmSeanZ @OphthoReg @drdamoeyes@MinakBhalla @ArunKirupakaran @SpencerFiona
📑 The RSM #COVID-19 learning hub page has been created to support healthcare professionals with access to #education and #learning#resources during the COVID-19 outbreak.
👇
https://t.co/o3VgGfZcZ8
We have published an Expression of Concern on the paper by Mehra et al on hydroxychloroquine and chloroquine published on May 22, 2020 https://t.co/yQ9irhRHxx
Among 1376 patients with #COVID19 admitted to a NYC hospital, 59% were treated with hydroxychloroquine. After adjustment for baseline characteristics, there was no significant association between hydroxychloroquine treatment and the composite end point of intubation or death.
Top image shows normal OCT scan with clearly defined EZ/IZ lines. Bottom image of an eye with retinitis pigmentosa showing loss of EZ and IZ lines representing photoreceptor abnormalities. #ophthalmology#eyedoc… https://t.co/881uMAM545
Congratulations to James Bainbridge and Robin Ali, winners of the 2018 Champalimaud Vision Award for the first successful gene therapy to cure an inherited human disease, and today lecturing on their groundbreaking work at #ARVO2019.
More info: https://t.co/2OasxxvWwu
“International ophthalmology is never just about doing volume surgery, it’s about a multiplier effect” – we speak to Steve Charles and his experience with sustainable teaching
#Ophthalmology#Ophthalmologist
https://t.co/oj3vFLiLF9
"..number of injections was inversely related to macular atrophy incidence"
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL... : RETINA https://t.co/Z5Xn1MHHjk #retina#intravitreal injections #AMD#lucentis#eylea